Table 4.
Expression profile of antibodies at different tumour localizations used in the study and measured in per cent/p value/r value
| Antibody | Floor of the mouth positive expression | Tongue positive expression | Other positive expression |
|---|---|---|---|
| p16 | 22.4/0.67/0.03 | 18.6/0.64/-0.03 | 22.9/0.72/0.03 |
| p21 | 70.6/0.82/-0.02 | 73.8/0.76/0.02 | 75.5/0.61/0.04 |
| p27 | 19.7/0.59/0.04 | 20/0.95/0 | 18,4/0.93/0.01 |
| p53 | 52,9/0.21/0.09 | 85.7/0.46/-0.05 | 55/0.32/-0.07 |
| Hif-1-alpha | 63.2/0.27/0.08 | 44.9/0.11/-0.12 | 59.1/0.7/0.03 |
| Glut 1 | 90.0/0.28/0.08 | 85.7/0.3/-0.07 | 96,9/0.84/-0.01 |
| Ca IX | 22.1/0.2/-0.09 | 33.3/0.17/0.1 | 27/1/0 |
| XIAP | 30.0/0.01/0.18 | 13.2/0.31/-0.07 | 12.5/0.04/0.15 |
| Hsp 70 | 10.8/0.89/-0.01 | 10.3/0.61/-0.04 | 10.9/0.34/-0.07 |
| a-Catenin | 64.8/0.71/-0.03 | 65.9/0.91/0.01 | 65.7/0.91/-0.01 |
| b-Catenin | 84.5/0.78/-0.02 | 86.7/0.09/0.12 | 82.1/0.08/-0.13 |
| g-Catenin | 66.7/0.98/0 | 64.3/0.84/0.02 | 63.6/0.89/0.01 |
| BCL-6 | 25.8/0.63/0.03 | 18.2/0.58/-0.04 | 19.1/0.84/-0.01 |
| Caspase 3 | 32.8/0.07/0.07 | 21.1/0.3/-0.03 | 22/0.3/-0.01 |
| C-kit | 16.2/0.49/0.05 | 6.8/0.36/-0.07 | 15.4/0.26/0.08 |
| Cyclin D1 | 51,5/0.63/-0.03 | 45.5/0.44/0.06 | 50/0.72/-0.03 |
| EGFR | 81.2/0.91/0.01 | 68.2/0.56/-0.04 | 73.5/0.85/0.01 |